Petros Antonoglou

Petros Antonoglou is a first-year Ph.D. student in Pharmaceutical Sciences at Rutgers University’s Ernest Mario School of Pharmacy. His research in the Glytsou Lab focuses on the molecular mechanisms of drug resistance in acute myeloid leukemia, and he is a co-author on a manuscript describing small-molecule OPA1 inhibitors. His past work includes a master’s thesis on hydrogels from decellularized intestine at B.S.R.C. “Alexander Fleming” in Athens, Greece, and a bachelor’s thesis on cancer resistance mechanisms at the Democritus University of Thrace. Beyond research, Petros organizes a graduate journal club and mentors undergraduate students. He aspires to a career in pharmaceutical research.